Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III
Conditions: COVID-19; Symptoms and Signs; COVID-19 Pandemic; Coronavirus Disease 2019; Coronavirus Infections Interventions: Combination Product: Chlorpheniramine Maleate 0.4% Nasal Spray; Combination Product: Placebo Sponsors: Dr. Ferrer BioPharma; Hospital CEMESA Cortés, San Pedro Sula, Honduras Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials